Skip to content
    Back to Database
    General Health IngredientsNatural

    Galacto-oligosaccharides

    Also known as: GOS, galactooligosaccharides, galacto-oligosaccharides

    Randomized trials and meta-analyses indicate that dietary fibres including GOS increase faecal Bifidobacterium abundance compared with low-fibre or placebo comparators; GOS-containing supplements or formulas have been shown to sustain higher bifidobacteria in infants and to alter maternal and infant stool microbiota and some short-chain fatty acids in trials cited here.

    Last reviewed: 2026-10-14 · 4 indexed studies

    Evidence Score
    73/100
    Prebiotic to support gut microbiotaIncluded in infant formula to promote bifidobacteriaMaternal supplementation during pregnancy/lactation to influence infant microbiome
    Data Completeness4/4 · 100%
    Evidence ScoreDosageSafetyLinked Studies

    Set your location for accurate regulatory status

    Saved on this device — no sign-in needed.

    Overview

    Galacto-oligosaccharides (GOS) are non-digestible oligosaccharides used as prebiotics to selectively stimulate beneficial gut bacteria. Human trials and meta-analyses report increases in bifidobacteria abundance and some changes in short-chain fatty acids following GOS-containing interventions.

    Mechanism & Function

    Mechanism of Action

    GOS resist digestion in the upper gastrointestinal tract and are fermented by resident microbes, preferentially stimulating bifidobacteria and lactobacilli and producing short-chain fatty acids that can affect local gut environment and host signalling.

    Physiological Role

    Selective fermentation substrate for commensal gut bacteria, leading to shifts in bacterial composition and microbial metabolites such as acetate and butyrate.

    Primary Pathways

    Microbial fermentationShort-chain fatty acid productionModulation of gut microbial composition

    Performance / Health Relevance

    Not an ergogenic agent; relevance is to gut microbial composition and downstream markers of gut and potentially immune/metabolic health. Effects are primarily microbial (increased bifidobacteria) and metabolic (changes in some faecal SCFAs).

    Evidence Review

    Overall73/100
    Human Clinical67/100
    Meta-Analysis79/100
    Mechanistic85/100
    Real-World59/100
    Safety80/100

    Practical Use & Dosage

    Minimum Effective Dose
    Effects on maternal and infant microbiota reported with 14.2 g/day GOS/FOS (maternal trial); meta-analysis includes a variety of fibre doses but specific minimum effective doses for GOS alone are not consistently reported in the provided abstracts.
    Optimal Range
    Not established from provided abstracts.
    Upper / Caution Level
    Not established from provided abstracts.
    Timing
    Daily administration in studies; often mixed into formula or taken as a powder supplement during pregnancy/lactation or added to infant formula.
    Best Format
    Powder mixed into formula or food; included as formula additive for infants.
    Bioavailability
    Non-digestible carbohydrate that reaches the colon intact and is fermented by gut bacteria.
    Absorption Considerations
    Fermentation can produce gas and short-chain fatty acids; individuals may experience transient gastrointestinal symptoms such as bloating or flatulence.

    Safety & Interactions

    Side Effects

    • •Bloating
    • •Flatulence
    • •Diarrhoea or loose stools at higher intakes

    Contraindications

    • Known intestinal obstruction or severe gastrointestinal motility disorders (consult clinician)

    Drug Interactions

    • •No specific drug interactions reported in the provided abstracts.

    Who Should Avoid

    • •Individuals with severe gastrointestinal disease should consult a clinician before use

    Monitoring

    Monitor gastrointestinal tolerance (bloating, gas, stool frequency/consistency). Seek medical advice if severe symptoms occur.

    Frequently Asked Questions

    Auto-generated from indexed evidence — dosage, safety, interactions, and more.

    When is Galacto-oligosaccharides typically used or indicated?

    Galacto-oligosaccharides is most commonly used for: Prebiotic to support gut microbiota, Included in infant formula to promote bifidobacteria, Maternal supplementation during pregnancy/lactation to influence infant microbiome. Selective fermentation substrate for commensal gut bacteria, leading to shifts in bacterial composition and microbial metabolites such as acetate and butyrate.

    How does Galacto-oligosaccharides work?

    GOS resist digestion in the upper gastrointestinal tract and are fermented by resident microbes, preferentially stimulating bifidobacteria and lactobacilli and producing short-chain fatty acids that can affect local gut environment and host signalling.

    What is the recommended dose of Galacto-oligosaccharides?

    The optimal range is Not established from provided abstracts.. with a minimum effective dose of Effects on maternal and infant microbiota reported with 14.2 g/day GOS/FOS (maternal trial); meta-analysis includes a variety of fibre doses but specific minimum effective doses for GOS alone are not consistently reported in the provided abstracts.. Best taken: Daily administration in studies; often mixed into formula or taken as a powder supplement during pregnancy/lactation or added to infant formula.. Upper / caution level: Not established from provided abstracts..

    What are the side effects of Galacto-oligosaccharides?

    Reported side effects include: Bloating; Flatulence; and Diarrhoea or loose stools at higher intakes. Monitoring: Monitor gastrointestinal tolerance (bloating, gas, stool frequency/consistency). Seek medical advice if severe symptoms occur.

    Does Galacto-oligosaccharides interact with medications?

    Known or theoretical interactions: No specific drug interactions reported in the provided abstracts.. Always check with a clinician before combining with prescription medication.

    Who should avoid Galacto-oligosaccharides?

    Galacto-oligosaccharides is generally not recommended for: Individuals with severe gastrointestinal disease should consult a clinician before use; and Known intestinal obstruction or severe gastrointestinal motility disorders (consult clinician).

    How strong is the evidence for Galacto-oligosaccharides?

    Evidence level: Moderate (overall score 73/100), based on 4 indexed studies on SuppIndex.

    Research & References (4)

    Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis.

    Meta-Analysis2018
    PubMed

    Systematic review and meta-analysis of 64 RCTs in healthy adults comparing dietary fibre interventions with placebo/low-fibre comparators, including subgroup analysis by fibre type.

    The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.

    Systematic Review2022
    PubMed

    Systematic review of probiotics, prebiotics, and synbiotics taken during pregnancy/lactation and effects on gut microbiota of cesarean-born infants; included interventions combining probiotics with prebiotics such as GOS.

    Diurnal rhythmicity of infant fecal microbiota and metabolites: A randomized controlled interventional trial with infant formula.

    RCT2024
    PubMed

    Randomized controlled trial of infant formula containing GOS versus formula with bifidobacteria or placebo in 210 infants, with longitudinal stool sampling over the first year.

    Maternal prebiotic supplementation during pregnancy and lactation modifies the microbiome and short chain fatty acid profile of both mother and infant.

    RCT2024
    PubMed

    Double-blind RCT where pregnant/lactating women received 14.2 g/day of a prebiotic powder (GOS:FOS 9:1) versus placebo, with maternal and infant stool sampled to assess microbiota and faecal SCFA.

    Related Ingredients

    Other top-rated ingredients in General Health Ingredients.

    Research Overview

    Moderate Evidence
    4Total Studies
    2Human Trials
    1Meta-Analyses
    2024Latest Study
    0Animal / In Vitro
    0Athlete Studies
    Primary data sourceGeneral Population
    Pooled evidence (meta-analysis / systematic review)Yes

    Cite this ingredient

    One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.

    Stable URL

    https://thesuppindex.com/ingredients/galacto-oligosaccharides

    SuppIndex. (2026). Galacto-oligosaccharides: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/galacto-oligosaccharides

    Based on 4 indexed studies · Evidence level: Moderate.

    Goal Ratings

    General Health
    Metabolic Health

    Stack Compatibility

    Commonly combined with probiotic strains (synbiotics) in trials; co-administration with probiotics has been used to target Bifidobacterium colonisation.

    Probiotics (synbiotic combinations)Other non-digestible fibres such as FOS/inulin in combination products